Attema AE. De TTO-methode en correctie voor tijdsvoorkeur. VGE Bulletin 2009; 26: 14-17.

Attema AE, Brouwer WBF. The correction of TTO-scores for utility curvature using a risk-free utility elicitation method. J Health Econ 2009; 28: 234-243.

Bago d’Uva T, Jones AM, Van Doorslaer EKA. Measurement of horizontal inequity in health care utilisation using European panel data. J Health Econ 2009; 28: 280-289.

Beeh KM, Hederer B, Glaab T, Müller A, Rutten-van Mölken MPMH, Kesten S, Vogelmeier C. Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations. Int J Chron Obstruct Pulmon Dis 2009; 4: 119-125.

Bijlenga D, Birnie E, Bonsel GJ. Feasibility, reliability, and validity of three health-state valuation methods using multiple-outcome vignettes on moderate-risk pregnancy at term. Value Health 2009; 12: 821-827.

Boormans EM, Birnie E, Bilardo CM, Oepkes D, Bonsel GJ, Van Lith JM. Karyotyping or rapid aneuploidy detection in prenatal diagnosis? The different views of users and providers of prenatal care. BJOG 2009; 116: 1396-1399.

Boot CR, Van Exel NJA, Van der Gulden JW. “My lung disease won’t go away, it’s there to stay”: profiles of adaptation to functional limitations in workers with asthma and COPD. J Occup Rehabil 2009; 19: 284-292.

Bouwmans CAM, Janssen J, Huijgens P, Uyl-de Groot CA. Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemia. J Med Econ 2009; 12: 164-169.

Brouwer WBF, Grootenboer S, Sendi P. The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence. Med Decis Making 2009; 29: 503-512.

Christiaans I, Van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients’ perspective. Am J Med Genet A 2009; 149A: 1444-1451.

Christiaans I, Van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM. Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 2009; 149A: 602-612.

Cramm JM, Finkenflügel H, Kuijsten R, Van Exel NJA. How employment support and social integration programmes are viewed by the intellectually disabled. J Intellect Disabil Res 2009; 53: 512-520.

Denktas S, Koopmans G, Birnie E, Foets M, Bonsel GJ. Ethnic background and differences in health care use: a national cross-sectional study of native Dutch and immigrant elderly in the Netherlands. Int J Equity Health 2009; 8: 35.

Drummond M, Barbieri M, Cook J, Glick H, Lis J, Malik F, Reed S, Rutten FFH, Sculpher M, Severens J. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health 2009; 12: 409-418.

Goossens LMA, Riemersma RA, Postma DS, Van der Molen T, Rutten-van Mölken MPMH. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.Adv Ther 2009; 26: 872-885.

Goossens LMA, Standaert B, Hartwig N, Hövels AM, Al MJ. Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions. Vaccine 2009; 27: 2531-2532.

Groenendijk AG, Birnie E, De Blok S, Adriaanse AH, Ankum WM, Roovers JP, Bonsel GJ. Clinical-decision taking in primary pelvic organ prolapse: the effects of diagnostic tests on treatment selection in comparison with a consensus meeting. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20: 711-719.

Groenendijk AG, Birnie E, Boeckxstaens GE, Roovers JP, Bonsel GJ. Anorectal function testing and anal endosonography in the diagnostic work-up of patients with primary pelvic organ prolapse. Gynecol Obstet Invest 2009; 67: 187-194.

Hakkaart L, Verboom P, Phillips R, Al MJ. The cost utility of solifenacin in the treatment of overactive bladder.Int Urol Nephrol 2009; 41: 293-298.

Hoefman RJ, De Klerk MMY, Foets M. Het aanvragen van voorzieningen door personen met een lichamelijke beperking: belemmeringen en hulp van het sociale netwerk. Tijdschrift voor Gezondheidswetenschappen 2009; 87: 20-26.

Holland J, Van Exel NJA, Schut FT, Brouwer WBF. Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system. Health Econ Policy Law 2009 Feb 25 [Epub ahead of print].

Hoogendoorn M, Van Wetering CR, Schols AM, Rutten-van Mölken MPMH. Is INTERdisicplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur Respir J 2009 Jul 2 [Epub ahead of print].

Hoogendoorn M, Van Wetering CR, Schols AM, Rutten-van Mölken MPMH. Self-report versus care provider registration of health care utilization: impact on cost and cost-utility. Int J Technol Assess Health Care 2009; 25: 588-595.

Van Hooren AC, Brouwer J, De Bree R, Hoekstra OS, Leemans CR, Uyl-de Groot CA. The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy. Eur Arch Otorhinolaryngol 2009; 266: 1441-1448.

Van Kippersluis H, Van Ourti T, O’Donnell O, Van Doorslaer EKA. Health and income across the life cycle and generations in Europe. J Health Econ 2009; 28: 818-830.

Krol M, Sendi P, Brouwer WBF. Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises. Value Health 2009; 12: 172-180.

McGhan WF, Al MJ, Doshi JA, Kamae I, Marx SE, Rindress D. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. Value Health 2009; 12: 1086-1099.

McGrail KM, Van Doorslaer EKA, Ross NA, Sanmartin C. Income-related health inequalities in Canada and the United States: a decomposition analysis. Am J Public Health 2009; 99: 1856-1863.

De Meijer CA, Koopmanschap MA, Koolman XH, Van Doorslaer EKA. The role of disability in explaining long-term care utilization. Med Care 2009; 47: 1156-1163.

Muntingh AD, Van der Feltz-Cornelis CM, Van Marwijk HW, Spinhoven P, Assendelft WJ, De Waal MW, Hakkaart-van Roijen L, Adèr HJ, Van Balkom AJ. Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomized controlled trial. BMC Health Serv Res 2009; 9: 159.

Niazkhani Z, Van der Sijs H, Pirnejad H, Redekop WK, Aarts J. Same system, different outcomes: comparing the transitions from two paper-based systems to the same computerized physician order entry system. Int J Med Inform 2009; 78: 170-181.

Niëns LM, Brouwer WBF. Better measures of affordability required. Lancet 2009; 373: 1081-1082.

Niëns LM, Lowery D. Gendered epidemiology: sexual equality and the prevalence of HIV/AIDS in Sub-Saharan Africa. Social Science Quarterly 2009; 90: 1134-1144.

Niezen MGH, De Bont A, Busschbach JJV, Cohen JP, Stolk EA. Finding legitimacy for the role of budget impact in drug reimbursement decisions. Int J Technol Assess Health Care 2009; 25: 49-55.

Van Nooten FE, Koolman X, Brouwer WBF. The influence of subjective life expectancy on health state valuations using a 10 year TTO. Health Econ 2009; 18: 549-558.

O’Donnell O, Nicolas Lopez A, Van Doorslaer EKA. Growing richer and taller: explaining change in the distribution of child nutritional status during Vietnam’s economic boom. Journal of Development Economics 2009; 88: 45-58.

Van Ourti T, Van Doorslaer EKA, Koolman X. The effect of income growth and inequality on health inequality: theory and empirical evidence from the European Panel. J Health Econ 2009; 28: 525-539.

Van de Poel E, O’Donnell O, Van Doorslaer EKA. Urbanization and the spread of diseases of affluence in China. Econ Hum Biol 2009; 7: 200-216.

Van de Poel E, O’Donnell O, Van Doorslaer EKA. What explains the rural-urban gap in infant mortality: household or community characteristics? Demography 2009; 46: 827-850.

Poley MJ, Stolk EA, Brouwer WBF. The use and impact of HTA in decision making in the Netherlands. Euro Observer 2009; 11: 7-8.

Rappange DR, Van Baal PHM, Van Exel NJA, Feenstra TL, Rutten FFH, Brouwer WBF. I costi sanitari indiretti (non correlati) durante gli anni di vita guadagnati: devono essere inclusi nelle valutazioni economiche degli interventi sanitari? Pharmacoeconomics Italian Research Articles 2009; 11: 55-70.

Rappange DR, Brouwer WBF, Van Exel NJA. Back to the consideration of future consequences scale: time to reconsider? J Soc Psychol 2009; 149: 562-584.

Rappange DR, Brouwer WBF, Hoogenveen RT, Van Baal PHM. Healthcare costs and obesity prevention: drug costs and other sector-specific consequences. Pharmacoeconomics 2009; 27: 1031-1044.

Ringburg AN, Buljac M, Stolk EA, Van Lieshout EM, Van Beeck EF, Patka P, Schipper IB. Willingness to pay for lives saved by Helicopter Emergency Medical Services. Prehosp Emerg Care 2009; 13: 37-43.

Rutten FFH. Zicht op zorgpakketten in Europa: resultaten van het Health Basket project. Health Management Forum 2009; 1: 28-30.

Rutten FFH, Uyl-de Groot CA, Vulto AG. Innovative payment systems for medicines in Europe. European Journal of Hospital Pharmacy: Practice 2009; 15: 60-62.

Rutten-van Mölken MPMH. Raising the awareness: projecting the future burden of COPD with the BOLD model. Eur Respir J 2009; 34: 787-789.

Rutten-van Mölken MPMH, Hoogendoorn M, Lamers LM. Holistic preferences for 1-year health profiles describing fluctuations in health: the case of chronic obstructive pulmonary disease. Pharmacoeconomics 2009; 27: 465-477.

Van Schie RM, Wadelius MI, Kamali F, Daly AK, Manolopoulos VG, De Boer A, Barallon R, Verhoef TI, Kirchheiner J, Haschke-Becher E, Briz M, Rosendaal FR, Redekop WK, Pirmohamed M, Van der Zee AH. Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics 2009; 10: 1687-1695.

Smit F, Willemse G, Meulenbeek P, Koopmanschap MA, Van Balkom A, Spinhoven P, Cuijpers P. Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial. Cost Eff Resour Alloc 2009; 7: 8.

Stolk EA, De Bont A, Van Halteren AR, Bijlmer RJ, Poley MJ. Role of health technology assessment in shaping the benefits package in The Netherlands. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 85-94.

Tan SS, Van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the allocation of overhead and capital costs to hospital services. Value Health 2008 Nov 19 [Epub ahead of print].

Tan SS, Oppe M, Zoet-Nugteren SK, Niezen RA, Kofflard MJM, Ten Cate FJ, Hakkaart-van Roijen L. A microcosting study of diagnostic tests for the detection of coronary artery disease in the Netherlands. Eur J Radiol 2008 Aug 12 [Epub ahead of print].

Tan SS, Rutten FFH, Van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ 2009; 10: 39-45.

Thunnissen MM, Duivenvoorden HJ, Busschbach JJV, Hakkaart-van Roijen L, Van Tilburg W, Verheul E, Trijsburg W. De effectiviteit van re-integratietraining versus boostersessies na kortdurende klinische psychotherapie: een gerandomiseerd klinisch onderzoek. Tijdschr Psychiatr 2009; 51: 75-86.

Uiters E, Devillé W, Foets M, Spreeuwenberg P, Groenewegen PP. Differences between immigrant and non-immigrant groups in the use of primary medical care: a systematic review. BMC Health Serv Res 2009; 9: 76.

Uyl-de Groot CA, Stupp R, Van der Bent M. Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 235-241.

Vehmeijer JT, Christiaans I, Van Langen IM, Birnie E, Bonsel GJ, Smets EM, Wilde AA. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.Neth Heart J 2009; 17: 464-469.